This new GCOA paper, published alongside the launch of the Aging with Heart Alliance, provides an analysis of cardiovascular disease (CVD) as the leading global cause of death and underscores the urgent need for a prevention-based approach. With the world undergoing an unprecedented aging megatrend, CVD prevention is more critical than ever, as aging populations…

Held in Berlin, Germany, on October 15th and 16th, and the United Nations Headquarters in New York City on December 3rd, 2024, Silver Economy Forum 2024: Leadership in an Aging World explored the opportunities associated with the growing global Silver Economy in a world of changing leadership and discussed what’s needed for successful leadership across issues…

On November 12, 2024, the Global Coalition on Aging and the Acton Institute brought together a diverse group of thought leaders—including senior clergy, scientists, G7 leaders, patient advocates, and private sector innovators—at the Pontifical Academy of Sciences in Vatican City for a critical discussion on antimicrobial resistance (AMR). The event, entitled Solving for Antimicrobial Resistance:…

In December 2024, IQVIA released a new white paper, developed in collaboration with GSK and GCOA, examining the significant economic and clinical burden of Respiratory Syncytial Virus (RSV) in older adults (age ≥60 years) across select high-income APEC countries, including China, Japan, South Korea, Canada, Singapore, New Zealand, Australia, Hong Kong, and Taiwan. The study…

Following the passage of the Inflation Reduction Act in 2022, healthcare systems in the United States are facing many changes in the name of saving costs and creating efficiencies. But do the benefits actually outweigh the costs?  GCOA’s issue brief, “Utilization Management Post-Inflation Reduction Act and the Threat to Healthy Aging,” addresses the unintended negative consequences…